Hemispherx BioPharma Revenue 2006-2018 | HEB

Current and historical revenue for Hemispherx BioPharma (HEB) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Hemispherx BioPharma revenue for the twelve months ending June 30, 2018 was $0.000B. Hemispherx BioPharma revenue for the three months ending June 30, 2018 was $0.000B, representing a 84.51% decline from the same quarter last year.
Hemispherx BioPharma Annual Revenue
(Millions of US $)
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
2008 $0
2007 $1
2006 $1
2005 $1
Hemispherx BioPharma Quarterly Revenue
(Millions of US $)
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $0
Q3 2011 $0
Q2 2011 $0
Q1 2011 $0
Q4 2010 $0
Q3 2010 $0
Q2 2010 $0
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008 $0
Q4 2007 $0
Q3 2007 $0
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.013B $0.000B
Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection and the experimental therapeutics Ampligen and Oragens. Alferon N Injection is approved for a category of STD infection, and Ampligen and Oragens represent a large portfolio experimental RNA nucleic acids being developed for globally important viral diseases, severely debilitating disorders and biodefense applications. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. The Company is actively engaged in further expansion of its intellectual property on a world wide basis to reflect the global distribution of the various disorders which its platform technologies address.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.784B 14.67
Gilead Sciences (GILD) United States $94.529B 10.49
Biogen (BIIB) United States $69.542B 14.74
Celgene (CELG) United States $63.563B 12.69
Illumina (ILMN) United States $47.904B 60.01
Vertex Pharmaceuticals (VRTX) United States $44.999B 102.37
Regeneron Pharmaceuticals (REGN) United States $40.441B 22.74
Alexion Pharmaceuticals (ALXN) United States $25.852B 19.43
BioMarin Pharmaceutical (BMRN) United States $17.938B 0.00
Incyte (INCY) United States $14.625B 491.43
Seattle Genetics (SGEN) United States $11.852B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.521B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.457B 60.73
Sarepta Therapeutics (SRPT) United States $8.654B 0.00
Bluebird Bio (BLUE) United States $8.557B 0.00
QIAGEN (QGEN) Netherlands $8.509B 27.82
BeiGene (BGNE) Cayman Islands $8.458B 0.00
Alkermes (ALKS) Ireland $6.916B 0.00
Bio-Techne Corp (TECH) United States $6.782B 45.58
Exact Sciences (EXAS) United States $5.995B 0.00
Exelixis (EXEL) United States $5.722B 18.64
Ligand Pharmaceuticals (LGND) United States $5.233B 46.35
Galapagos (GLPG) Belgium $5.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.919B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.564B 0.00
Immunomedics (IMMU) United States $3.514B 0.00
Horizon Pharma Public (HZNP) Ireland $3.428B 19.41
Akcea Therapeutics (AKCA) United States $3.076B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.058B 0.00
China Biologic Products (CBPO) China $3.048B 20.13
Array BioPharma (ARRY) United States $2.984B 0.00
Ascendis Pharma (ASND) Denmark $2.970B 0.00
Emergent Biosolutions (EBS) United States $2.965B 23.61
Myriad Genetics (MYGN) United States $2.952B 35.31
Medicines (MDCO) United States $2.941B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.733B 0.00
Global Blood Therapeutics (GBT) United States $2.566B 0.00
Amicus Therapeutics (FOLD) United States $2.500B 0.00
Halozyme Therapeutics (HALO) United States $2.478B 33.02
CRISPR THERAPTC (CRSP) Switzerland $2.316B 0.00
Spark Therapeutics (ONCE) United States $2.306B 0.00
MyoKardia (MYOK) United States $2.267B 0.00
Acceleron Pharma (XLRN) United States $2.226B 0.00
Repligen (RGEN) United States $2.169B 72.82
Momenta Pharmaceuticals (MNTA) United States $2.161B 0.00
Reata Pharmaceuticals (RETA) United States $2.141B 0.00
REGENXBIO (RGNX) United States $2.131B 33.48
Cambrex (CBM) United States $2.110B 16.92
AnaptysBio (ANAB) United States $2.070B 0.00
Genomic Health (GHDX) United States $1.965B 109.58
Mirati Therapeutics (MRTX) United States $1.940B 0.00
G1 THERAPEUTICS (GTHX) United States $1.918B 0.00
Clovis Oncology (CLVS) United States $1.856B 0.00
Arena Pharmaceuticals (ARNA) United States $1.764B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.715B 0.00
Rubius Therapeutics (RUBY) United States $1.647B 0.00
Aimmune Therapeutics (AIMT) United States $1.636B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.629B 0.00
Atara Biotherapeutics (ATRA) United States $1.628B 0.00
Insmed (INSM) United States $1.617B 0.00
Puma Biotechnology (PBYI) United States $1.593B 0.00
Allakos (ALLK) United States $1.575B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Denali Therapeutics (DNLI) United States $1.492B 0.00
Myovant Sciences (MYOV) United Kingdom $1.433B 0.00
Innoviva (INVA) United States $1.425B 9.14
Lion Biotechnologies (IOVA) United States $1.424B 0.00
Editas Medicine (EDIT) United States $1.424B 0.00
Solid Biosciences (SLDB) United States $1.403B 0.00
BIOHAVEN PHARM (BHVN) United States $1.399B 0.00
IMMURON LTD (IMRN) Australia $1.379B 0.00
WAVE Life Sciences (WVE) Singapore $1.372B 0.00
UniQure (QURE) Netherlands $1.352B 0.00
Acorda Therapeutics (ACOR) United States $1.339B 27.92
Deciphera Pharmaceuticals (DCPH) United States $1.317B 0.00
Coherus BioSciences (CHRS) United States $1.289B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.269B 0.00
Audentes Therapeutics (BOLD) United States $1.233B 0.00
Intellia Therapeutics (NTLA) United States $1.204B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.188B 0.00
Cellectis (CLLS) France $1.177B 0.00
Retrophin (RTRX) United States $1.152B 0.00
Athenex (ATNX) United States $1.147B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.144B 2185.00
Zai Lab Unsponsored ADR (ZLAB) China $1.122B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.100B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.084B 0.00
DBV Technologies (DBVT) France $1.072B 0.00
Intra-Cellular Therapies (ITCI) United States $1.044B 0.00
NeoGenomics (NEO) United States $1.034B 181.00
CytomX Therapeutics (CTMX) United States $1.011B 0.00
Apellis Pharmaceuticals (APLS) United States $0.983B 0.00
Revance Therapeutics (RVNC) United States $0.968B 0.00
AVROBIO (AVRO) United States $0.957B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.798B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.794B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.793B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.790B 0.00
Dynavax Technologies (DVAX) United States $0.789B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.788B 0.00
Aptinyx (APTX) United States $0.764B 0.00
Heska (HSKA) United States $0.753B 64.78
Cara Therapeutics (CARA) United States $0.743B 0.00
Epizyme (EPZM) United States $0.733B 0.00
Geron (GERN) United States $0.720B 0.00
InflaRx (IFRX) Germany $0.706B 0.00
Kura Oncology (KURA) United States $0.701B 0.00
UNITY Biotechnology (UBX) $0.670B 0.00
ANI Pharmaceuticals (ANIP) United States $0.667B 13.21
Eidos Therapeutics (EIDX) United States $0.667B 0.00
Abeona Therapeutics (ABEO) United States $0.635B 0.00
Viking Therapeutics (VKTX) United States $0.634B 0.00
Sorrento Therapeutics (SRNE) United States $0.625B 0.00
Anika Therapeutics (ANIK) United States $0.614B 25.83
Verastem (VSTM) United States $0.609B 0.00
Fate Therapeutics (FATE) United States $0.598B 0.00
Mesoblast (MESO) Australia $0.593B 0.00
UROGEN PHARMA (URGN) Israel $0.591B 0.00
Arcus Biosciences (RCUS) United States $0.590B 0.00
Prothena (PRTA) Ireland $0.578B 0.00
AC Immune SA (ACIU) Switzerland $0.564B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.559B 0.00
Replimune (REPL) United States $0.538B 0.00
Arbutus Biopharma (ABUS) Canada $0.504B 0.00
Kindred Biosciences (KIN) United States $0.487B 0.00
Novavax (NVAX) United States $0.478B 0.00
Vericel (VCEL) United States $0.474B 0.00
Stemline Therapeutics (STML) United States $0.469B 0.00
Five Prime Therapeutics (FPRX) United States $0.469B 0.00
Magenta Therapeutics (MGTA) United States $0.455B 0.00
Aduro Biotech (ADRO) United States $0.455B 0.00
Zymeworks (ZYME) Canada $0.453B 0.00
GTx (GTXI) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.438B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Zealand Pharma (ZEAL) Denmark $0.434B 0.00
Merus (MRUS) Netherlands $0.432B 0.00
MiMedx (MDXG) United States $0.432B 18.52
Senesco Technologies (ELOX) United States $0.417B 0.00
Unum Therapeutics (UMRX) United States $0.409B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.407B 0.00
Inovio Pharmaceuticals (INO) United States $0.405B 0.00
Evelo Biosciences (EVLO) United States $0.395B 0.00
Cytokineticsorporated (CYTK) United States $0.393B 0.00
Kadmon Holdings (KDMN) United States $0.382B 0.00
Vital Therapies (VTL) United States $0.381B 0.00
MediciNova (MNOV) United States $0.381B 0.00
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.369B 0.00
Sinovac Biotech (SVA) China $0.368B 0.00
Albireo Pharma (ALBO) United States $0.361B 0.00
Syros Pharmaceuticals (SYRS) United States $0.353B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.351B 0.00
RA PHARMCTL INC (RARX) United States $0.341B 0.00
PDL BioPharma (PDLI) United States $0.339B 4.76
Seres Therapeutics (MCRB) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.326B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.324B 0.00
Kezar Life Sciences (KZR) United States $0.321B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.316B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.310B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.307B 0.00
Kala Pharmaceuticals (KALA) United States $0.299B 0.00
ResTORbio (TORC) United States $0.298B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.296B 0.00
Osiris Therapeutics (OSIR) United States $0.296B 0.00
Selecta Biosciences (SELB) United States $0.284B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.278B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.277B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.275B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Constellation Pharmaceuticals (CNST) United States $0.269B 0.00
Celcuity (CELC) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.253B 0.00
MeiraGTx Holdings (MGTX) United States $0.253B 0.00
NantKwest (NK) United States $0.252B 0.00
Axovant Sciences (AXON) United Kingdom $0.250B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.241B 0.00
Idera Pharmaceuticals (IDRA) United States $0.239B 0.00
Cohbar (CWBR) United States $0.238B 0.00
Liquidia Technologies (LQDA) United States $0.230B 0.00
Allena Pharmaceuticals (ALNA) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.221B 0.00
Kamada (KMDA) Israel $0.219B 17.03
Clearside Biomedical (CLSD) United States $0.217B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Enzo Biochem (ENZ) United States $0.192B 0.00
Agenus (AGEN) United States $0.189B 0.00
Protagonist Therapeutics (PTGX) United States $0.188B 0.00
Signal Genetics (MGEN) United States $0.185B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Menlo Therapeutics (MNLO) United States $0.177B 0.00
BioDelivery Sciences (BDSI) United States $0.170B 0.00
OVID THERAPEUTC (OVID) United States $0.169B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Krystal Biotech (KRYS) United States $0.168B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Mustang Bio (MBIO) United States $0.168B 0.00
MannKind (MNKD) United States $0.164B 0.00
TOCAGEN INC (TOCA) United States $0.162B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.155B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.152B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
XBiotech (XBIT) United States $0.149B 0.00
Organovo Holdings (ONVO) United States $0.143B 0.00
Pluristem Therapeutics (PSTI) Israel $0.140B 0.00
Intec Pharma (NTEC) Israel $0.133B 0.00
XOMA (XOMA) United States $0.133B 14.00
Cerecor (CERC) United States $0.132B 16.29
Vaccinex (VCNX) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.132B 0.00
Monster Digital (INNT) United States $0.131B 0.00
Provention Bio (PRVB) United States $0.130B 0.00
BioXcel Therapeutics (BTAI) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.123B 0.00
Aptevo Therapeutics (APVO) United States $0.122B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
VBI Vaccines (VBIV) United States $0.121B 0.00
Cidara Therapeutics (CDTX) United States $0.120B 0.00
Trevena (TRVN) United States $0.119B 0.00
PSivida (EYPT) United States $0.108B 0.00
Tapimmune (TPIV) United States $0.107B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.106B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Aptose Biosciences (APTO) Canada $0.103B 0.00
NewLink Genetics (NLNK) United States $0.101B 0.00
ScPharmaceuticals (SCPH) United States $0.100B 0.00
Orgenesis (ORGS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.095B 0.00
Alcobra (ARCT) Israel $0.088B 0.00
Ophthotech (OPHT) United States $0.087B 0.56
Proteostasis Therapeutics (PTI) United States $0.086B 0.00
Eleven Biotherapeutics (SESN) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.078B 0.00
Histogenics (HSGX) United States $0.076B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Sophiris Bio (SPHS) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
VIVUS (VVUS) United States $0.066B 0.00
Axsome Therapeutics (AXSM) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
TRACON Pharmaceuticals (TCON) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Novelion Therapeutics (NVLN) Canada $0.057B 0.00
Oncobiologics (ONS) United States $0.056B 0.00
Neothetics (EVFM) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Chiasma (CHMA) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
Celsion (CLSN) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Proteon Therapeutics (PRTO) United States $0.043B 0.00
GENPREX INC (GNPX) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
CytRx (CYTR) United States $0.037B 0.00
VTv Therapeutics (VTVT) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.031B 0.00
AEterna Zentaris (AEZS) United States $0.030B 60.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
Arsanis (ASNS) United States $0.026B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.020B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.16
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Galena Biopharma (SLS) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.000B 0.00